The report is designed to be accessible to everyone — most importantly for people with CF, family member, carers and healthcare professionals.
The report summarises a range of information including:
- UK enrolment in CF clinical trials, and the range of therapies in development
- Sponsor/pharmaceutical company engagement
- Summary of the CF community's involvement in designing and shaping trials, including results from the annual trials survey
- Future plans for the Trials Accelerator in supporting the delivery of clinical trials to the UK CF community
Read the 2020 Trials Accelerator Impact Report
The 2020 Trials Accelerator Impact Report (1.74MB) is now available to download.
As this is our first annual Impact Report, this report highlights the achievements of the programme since its launch in 2017.
If you would like to see further information on the work of the Clinical Trials Accelerator Platform then please visit our Clinical Trials Digital Hub.
If you have any questions on the report or about CF clinical trials in the UK, please email us at email@example.com.